9Baine WB,Yu W,Summe JP,et al. Epidemiologic trends in the evaluation and treatment of lower urinary tract symptoms in elderly male medicare patients from 1991 to 1995. J Urol, 1998,160:816-820.
10Lepor H. α-aderenergic blocker for the treatment of benign prostatic hyperplasia.In:Lepor H eds. Prostatic diseases. Philadelphia: Saunders ,2001. 297-307.
3Chou EC, Capello SA, Levin RM,et al. Excitatory cl-adrenergic receptors predominate over inhibitory 13-receptors in rabbit dorsal detrusor [J]. J Urol, 2003,170 : 2503-2507.
4Morton JS, Daly C J, Jackson VM,et al. ctlA-Adrenoceptors mediate contractions to phenylephrine in rabbit penile arteries [J]. Br J Pharmacol, 2007,150( 1 ) : 112-120.
5Cheng JT, Kuo DY. Both alphal-adrenergic and D (1)-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice [J]. Neuroseience Letters, 2003,347 (2) : 136-138.
6刘震.浅谈前列腺增生症的防治常识[J].健康必读,2013,12(11):165.
7Velusami CC, Agarwal A, Mookambeswaran V. Effect ot nelumbo nucifera petal extracts on lipase, adipogenesis, adipolysis, and cen- tral peceptors of obesity [ J ]. Evid-Based Complement Actermat Med, 2013,2013 (2013) :1-7.